Aclara and Third Wave Collaborate on Gene Expression Profiling Product, Say Genotyping Next | GenomeWeb

SAN DIEGO, October 25 — Aclara BioSciences and Third Wave Technologies on Thursday announced a collaboration to develop and commercialize multiplexed gene expression research products that couple Aclara’s eTag sequence-labeling technology with Third Wave's Invader platform. 

The companies said that their combined technologies would enable customers to profile many genes simultaneously in a single reaction directly from crude cell lysates, without the need for sample prep or PCR. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.